All Clinical Trials

A listing of 23116 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Trials

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Healthy Participants Needed (Colonoscopy + Cancer Screening)

Recruiting

Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.

Conditions:

Healthy

Healthy Volunteers

Healthy Subjects

Healthy Volunteer

Healthy Participants

Learn More

Featured Therapy

Unique Treatment for High Blood Pressure

Worried about high blood pressure? Think beyond typical high blood pressure treatments.

People who may be candidates for this procedure:

• Are at least 18 years old
• Have been unable to manage their high blood pressure with medications or lifestyle changes alone¹

Learn about a safe and effective procedure that may help reduce high blood pressure. See if you qualify today.

¹ Kandzari DE, et al. J Am Coll Cardiol. Nov 7, 2023;82(19):1809-1823.

Conditions:

High Blood Pressure

High Blood Pressure (& [Essential Hypertension])

High Blood Pressure (Hypertension).

Hypertension

Essential Hypertension

Learn More

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

Featured Trial

Discover Clinical Trials In Your Area (Compensation Provided)

Recruiting

Clinical trials in your area are actively enrolling — and they compensate you for your time. Finding the right one has never been easier.

- Matched to trials in your zip code
- Compensation for time & travel
- Free or low-cost treatments available
- No experience or medical background needed
- Takes just 30 seconds to see if you qualify

Conditions:

Healthy

Healthy Volunteers

Learn More

Featured Offer

Lose 20% of Body Weight With GLP-1's

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to tirzepatide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss (up to 22% of body weight).

Get $50 off your first order using promo code: policy-lab-50

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Featured Trial

COVID-19 Vaccine Clinical Trial (Compensation Provided)

Recruiting

Healthy adults ages 50-64 may qualify. You may be eligible if you haven’t received a COVID-19 vaccine and haven’t had COVID-19 in the last 90 days.

Qualified participants may receive compensation for time and travel.

Conditions:

Healthy

Vaccine

COVID19

COVID-19

COVID-19 Vaccine

Learn More

Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

NCT03193151

Recruiting

INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biopsy performed as standard-of-care for indications, or by center protocol, will be used for gene expression study.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/14/2025

Locations: University of California San Francisco, Transplant Research Unit, San Francisco, California +14 locations

Conditions: Liver Dysfunction

Learn More ›

The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

NCT03482245

Recruiting

Our data suggest that modulating the characteristics of light carries the potential to modify the host response to injury and critical illness and thus, improve outcome. The ability to modify the host response to the stress of major operations and sepsis carries immense potential to improve patient care. The primary purpose of this study is to determine if exposure to bright blue (442nm) enriched light, by comparison to ambient white fluorescent light, reduces the inflammatory response or organ... Read More

Gender:

ALL

Ages:

Between 18 years and 65 years

Trial Updated:

07/14/2025

Locations: Barnes Jewish Hospital, Saint Louis, Missouri

Conditions: Pneumonia, Necrotizing Soft Tissue Infection, Infection Joint, Intraabdominal Infections

Learn More ›

Bimatoprost as a Treatment for Graves' Orbitopathy

NCT03708627

Recruiting

Testing whether Bimatoprost, a topical eye drop used for glaucoma, can be used to induce periorbital fat atrophy in patients with Graves' disease

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/14/2025

Locations: University of Washington, Seattle, Washington

Conditions: Graves Ophthalmopathy

Learn More ›

Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors

NCT03750227

Recruiting

This phase III trial studies the side effects and how well stereotactic radiosurgery (SRS) works before or after surgery in patients with tumors that has spread to the brain or that can be removed by surgery. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/14/2025

Locations: Mayo Clinic in Arizona, Scottsdale, Arizona +3 locations

Conditions: Metastatic Malignant Neoplasm in the Brain, Malignant Solid Neoplasm

Learn More ›

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

NCT03785249

Recruiting

This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with advanced solid tumors that have a KRAS G12C mutation.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/14/2025

Locations: ONeal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, Alabama +227 locations

ONeal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, Alabama

Alaska Oncology and Hematology, Anchorage, Alaska

Mayo Clinic Arizona - Phoenix Campus, Phoenix, Arizona

Local Institution - 001-807, Scottsdale, Arizona

Local Institution - 001-873-A, Tucson, Arizona

USOR - Arizona Oncology - Tucson - Rudasill, Tucson, Arizona

Local Institution - 001-840-B, Bellflower, California

Beverly Hills Cancer Center, Beverly Hills, California

City of Hope - Duarte (Main Campus), Duarte, California

Local Institution - 001-850-K, Dublin, California

Providence Medical Foundation - Virginia K. Crosson Cancer Center - Fullerton, Fullerton, California

Local Institution - 001-840-C, Harbor City, California

University of California San Diego Moores Cancer Center, La Jolla, California

TRIO - Cancer and Blood Specialty Clinic, Los Alamitos, California

Southern California Permanente Medical Group - Los Angeles Medical Center, Los Angeles, California

Valkyrie Clinical Trials, Los Angeles, California

Hoag Memorial Hospital Presbyterian - Newport Beach, Newport Beach, California

Local Institution - 001-850-B, Oakland, California

University of California Irvine Medical Center, Orange, California

Local Institution - 001-850-C, Roseville, California

Local Institution - 001-850-J, Sacramento, California

Local Institution - 001-850-D, Sacramento, California

California Cancer Associates for Research and Excellence (cCARE) - San Diego 4S Ranch, San Diego, California

Local Institution - 001-840-A, San Diego, California

Local Institution - 001-850-H, San Francisco, California

Local Institution - 001-850-E, San Francisco, California

Local Institution - 001-850-F, San Jose, California

Local Institution - 001-850-A, San Leandro, California

Ridley - Tree Cancer Center - Santa Barbara, Santa Barbara, California

Local Institution - 001-850-I, Santa Clara, California

Local Institution - 001-884-A, Solvang, California

Kaiser Permanente - Vallejo Medical Center, Vallejo, California

Local Institution - 001-850-G, Walnut Creek, California

USOR - Rocky Mountain Cancer Centers - Aurora, Aurora, Colorado

UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora, Colorado

Local Institution - 001-872-H, Boulder, Colorado

Local Institution - 001-872-E, Colorado Springs, Colorado

Local Institution - 001-872-L, Colorado Springs, Colorado

Local Institution - 001-872-B, Denver, Colorado

Local Institution - 001-951 - A, Denver, Colorado

Local Institution - 001-951 - B, Denver, Colorado

Cancer Centers of Colorado - St. Marys Regional Hospital, Grand Junction, Colorado

SCL Health - Saint Joseph Hospital Cancer Center, Lafayette, Colorado

Local Institution - 001-872-A, Lakewood, Colorado

Local Institution - 001-872-D, Littleton, Colorado

Local Institution - 001-872-K, Lone Tree, Colorado

Local Institution - 001-872-C, Longmont, Colorado

Local Institution - 001-872-J, Parker, Colorado

Local Institution - 001-872-F, Pueblo, Colorado

Local Institution - 001-872-G, Pueblo, Colorado

Local Institution - 001-872-I, Thornton, Colorado

Yale Cancer Center, New Haven, Connecticut

USOR - Medical Oncology Hematology Consultants, Newark, Delaware

Local Institution - 001-929i, Altamonte Springs, Florida

Boca Raton Clinical Research Associates, Inc., Boca Raton, Florida

Local Institution - 001-922A, Bonita Springs, Florida

Local Institution - 001-922D, Bradenton, Florida

Local Institution - 001-929c, Brandon, Florida

Local Institution - 001-922E, Cape Coral, Florida

Local Institution - 001-929g, Clearwater, Florida

Local Institution - 001-926b, Daytona Beach, Florida

SCRI - Florida Cancer Specialists - South Region Research Office, Fort Myers, Florida

Local Institution - 001-922B, Fort Myers, Florida

Local Institution - 001-922C, Fort Myers, Florida

Local Institution - 001-929b, Gainesville, Florida

Mayo Clinic - Jacksonville, Jacksonville, Florida

Local Institution - 001-929m, Lady Lake, Florida

Local Institution - 001-929e, Largo, Florida

Local Institution - 001-929n, Lecanto, Florida

Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida

Miami Cancer Institute, Miami, Florida

Local Institution - 001-922F, Naples, Florida

Local Institution - 001-922G, Naples, Florida

Florida Cancer Affiliates - Ocala - Main, Ocala, Florida

Local Institution - 001-929p, Ocala, Florida

Local Institution - 001-929j, Orange City, Florida

Mid Florida Cancer Centers - Orange City, Orange City, Florida

Local Institution - 001-929l, Orlando, Florida

Woodlands Medical Specialists, Pensacola, Florida

Local Institution - 001-922H, Port Charlotte, Florida

Local Institution - 001-929a, Saint Petersburg, Florida

SCRI - Florida Cancer Specialists - North Region Research Office, Saint Petersburg, Florida

Local Institution - 001-922I, Sarasota, Florida

Local Institution - 001-922J, Sarasota, Florida

Local Institution - 001-929h, Spring Hill, Florida

Local Institution - 001-926d, Stuart, Florida

Local Institution - 001-929d, Tampa, Florida

Local Institution - 001-929k, Tavares, Florida

Local Institution - 001-929f, Trinity, Florida

Local Institution - 001-922K, Venice, Florida

Local Institution - 001-922L, Venice, Florida

Local Institution - 001-926c, Vero Beach, Florida

Local Institution - 001-926a, Wellington, Florida

SCRI - Florida Cancer Specialists - East Region Research Office, West Palm Beach, Florida

Local Institution - 001-929o, Winter Park, Florida

University Cancer & Blood Center (UCBC) - Athens, Athens, Georgia

Local Institution - 001-835-C, Austell, Georgia

Local Institution - 001-835-E, Austell, Georgia

Local Institution - 001-835-D, Carrollton, Georgia

Local Institution - 001-835-F, Carrollton, Georgia

Local Institution - 001-835-A, Cartersville, Georgia

Local Institution - 001-835-B, Douglasville, Georgia

Northwest Georgia Oncology Centers Wellstar - Marietta, Marietta, Georgia

Affiliated Oncologists, LLC, Chicago Ridge, Illinois

Local Institution - 001-828, Chicago, Illinois

USOR - Illinois Cancer Specialists - Niles, Niles, Illinois

Memorial Hospital, South Bend, Indiana

University of Iowa, Iowa City, Iowa

University of Kansas Medical Center, Westwood, Kansas

University of Kentucky, Lexington, Kentucky

SCRI - Hematology Oncology Clinic - Baton Rouge, Baton Rouge, Louisiana

MaineHealth Cancer Care - Biddeford, Biddeford, Maine

Local Institution - 001-881-B, Brandywine, Maryland

Maryland Oncology Hematology - Columbia, Columbia, Maryland

Local Institution - 001-881-A, Silver Spring, Maryland

Dana-Farber Cancer Institute, Boston, Massachusetts

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Henry Ford Health System, Detroit, Michigan

Local Institution - 001-842-A, Farmington Hills, Michigan

Local Institution - 001-838-F, Coon Rapids, Minnesota

Local Institution - 001-838-E, Edina, Minnesota

Local Institution - 001-875 - D, Edina, Minnesota

Local Institution - 001-838-D, Maplewood, Minnesota

Local Institution - 001-875 - A, Maplewood, Minnesota

Local Institution - 001-838-C, Minneapolis, Minnesota

USOR - Minnesota Oncology - Minneapolis Clinic, Minneapolis, Minnesota

Local Institution - 001-838-G, Minneapolis, Minnesota

Local Institution - 001-822-A, Minneapolis, Minnesota

Masonic Cancer Center, Minneapolis, Minnesota

Mayo Clinic - Rochester, Rochester, Minnesota

Metro-Minnesota Community Oncology Research Consortium (MMCORC), Saint Louis Park, Minnesota

Local Institution - 001-838-B, Saint Louis Park, Minnesota

Local Institution - 001-838-A, Saint Paul, Minnesota

Local Institution - 001-875 - B, Saint Paul, Minnesota

Local Institution - 001-875 - C, Woodbury, Minnesota

Central Care Cancer Center - Bolivar, Bolivar, Missouri

Goldschmidt Cancer Center, Jefferson City, Missouri

Sisters of Charity of Leavenworth Health St. Marys, Billings, Montana

Local Institution - 001-544B, Omaha, Nebraska

Methodist Estabrook Cancer Center, Omaha, Nebraska

Local Institution - 001-544A, Omaha, Nebraska

University of Nebraska Medical Center, Omaha, Nebraska

Local Institution - 001-860A, Henderson, Nevada

Local Institution - 001-860C, Henderson, Nevada

Local Institution - 001-860B, Henderson, Nevada

USOR - Comprehensive Cancer Centers of Nevada - Southeast Henderson, Henderson, Nevada

Local Institution - 001-860E, Las Vegas, Nevada

Local Institution - 001-860D, Las Vegas, Nevada

Local Institution - 001-860F, Las Vegas, Nevada

New York Oncology Hematology - Albany Medical Center, Albany, New York

Roswell Park Comprehensive Cancer Center, Buffalo, New York

Local Institution - 001-832, Lake Success, New York

Perlmutter Cancer Center - 34th Street, New York, New York

Local Institution - 001-583, New York, New York

Memorial Sloan Kettering Cancer Center - New York, New York, New York

University of North Carolina Hospitals, Chapel Hill, North Carolina

FirstHealth Outpatient Cancer Center, Pinehurst, North Carolina

The Christ Hospital, Cincinnati, Ohio

University of Cincinnati Health Barrett Cancer Center, Cincinnati, Ohio

Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio

Local Institution - 001-833 - H, Columbus, Ohio

Local Institution - 001-833 - C, Columbus, Ohio

Local Institution - 001-833 - J, Columbus, Ohio

Local Institution - 001-833 - A, Columbus, Ohio

Local Institution - 001-833 - F, Columbus, Ohio

The Ohio State University College of Medicine, Columbus, Ohio

Local Institution - 001-833 - D, Columbus, Ohio

Local Institution - 001-833 - I, Columbus, Ohio

SCRI - Mark H. Zangmeister Cancer Center, Columbus, Ohio

Local Institution - 001-833 - B, Columbus, Ohio

Local Institution - 001-833 - G, Columbus, Ohio

Local Institution - 001-833 - E, Gahanna, Ohio

Kettering Health Cancer Center - Main Campus, Kettering, Ohio

Local Institution - 001-836-A, Kettering, Ohio

Cancer Centers of Southwest Oklahoma - Leah M. Fitch Cancer Center, Lawton, Oklahoma

Local Institution - 001-580, Oklahoma City, Oklahoma

Local Institution - 001-584, Tulsa, Oklahoma

Local Institution - 001-586-A, Bend, Oregon

St. Charles Health System, Bend, Oregon

Willamette Valley Cancer Institute and Research Center - Eugene, Eugene, Oregon

Lehigh Valley Physician Group Hematology Oncology, Allentown, Pennsylvania

Local Institution - 001-837-A, Bethlehem, Pennsylvania

Penn State Cancer Institute, Hershey, Pennsylvania

USOR - Alliance Cancer Specialists - Media (Cancer Center at Riddle Memorial Hospital), Media, Pennsylvania

USOR - Charleston Hematology Oncology Associates, Charleston, South Carolina

Medical University of South Carolina, Charleston, South Carolina

Local Institution - 001-801-G, Gallatin, Tennessee

Local Institution - 001-801-A, Hendersonville, Tennessee

Local Institution - 001-801-D, Hermitage, Tennessee

Local Institution - 001-801-F, Murfreesboro, Tennessee

Local Institution - 001-801-B, Nashville, Tennessee

Tennessee Oncology - Nashville - Centennial Clinic - Medical Oncology, Nashville, Tennessee

Local Institution - 001-801-E, Nashville, Tennessee

Local Institution - 001-801-C, Nashville, Tennessee

Local Institution - 001-888-B, Arlington, Texas

USOR - Texas Oncology Dallas Fort Worth West (DFWW) - Arlington South, Arlington, Texas

USOR - Texas Oncology - Austin Central, Austin, Texas

Local Institution - 001-848a, Conroe, Texas

Mary Crowley Cancer Research - Medical City Hospital, Dallas, Texas

USOR - Texas Oncology - Dallas Fort Worth (DFW) - Presbyterian Cancer Center Dallas, Dallas, Texas

USOR - Texas Oncology - Dallas Fort Worth (DFW) - Baylor Charles A. Sammons Cancer Center, Dallas, Texas

USOR - Texas Oncology Northeast Texas - Denison, Denison, Texas

Texas Oncology - Dallas Fort Worth (DFW) - Fort Worth, Fort Worth, Texas

Oncology Consultants - Texas Medical Center, Houston, Texas

University of Texas MD Anderson Cancer Center, Houston, Texas

Local Institution - 001-935A, Houston, Texas

Local Institution - 001-999, Irving, Texas

Local Institution - 001-935D, Kingwood, Texas

Lumi Research, Kingwood, Texas

USOR - Texas Oncology - Midland Allison Cancer Center, Midland, Texas

START Center for Cancer Care, San Antonio, Texas

Local Institution - 001-935B, Shenandoah, Texas

Local Institution - 001-935C, Spring, Texas

Texas Oncology - Sugar Land, Sugar Land, Texas

Local Institution - 001-935E, Tomball, Texas

Texas Oncology - Northeast Texas Cancer and Research Institute - Tyler, Tyler, Texas

Texas Oncology - Waco, Waco, Texas

Local Institution - 001-919, Fairfax, Virginia

NEXT Virginia, Fairfax, Virginia

Hematology Oncology Associates of Fredericksburg, Fredericksburg, Virginia

USOR - Virginia Oncology Associates - Newport News, Newport News, Virginia

Local Institution - 001-882-A, Norfolk, Virginia

Local Institution - 001-890-A, Norfolk, Virginia

Virginia Cancer Institute - West End, Richmond, Virginia

Fred Hutchinson Cancer Research Center, Seattle, Washington

USOR - Northwest Cancer Specialists, P.C. dba Compass Oncology - Vancouver Cancer Center, Vancouver, Washington

University Wisconsin Carbone Cancer Center, Madison, Wisconsin

PanOncology Trials - Rio Piedras Medical Center, San Juan, Not set

Conditions: Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease

Learn More ›

Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies

NCT03838926

Recruiting

The aim of this study is to investigate the safety and tolerability of trichostatin A in individuals with relapsed or refractory hematologic malignancies.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/14/2025

Locations: Vanda Investigational Site, Washington, District of Columbia +10 locations

Conditions: Relapsed or Refractory Hematologic Malignancies

Learn More ›

A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies

NCT03888105

Recruiting

This study is researching an investigational drug, odronextamab, in adult patients B-cell non-Hodgkin's lymphoma (B-NHL). The main purpose of this study is to assess the effectiveness of odronextamab in destroying cancer cells and to learn more about the safety of odronextamab. The study is looking at several other research questions, including: * To see if odronextamab works to destroy cancer cells * Side effects that may be experienced by people taking odronextamab * How odronextamab works... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/14/2025

Locations: Rush University Medical Center, Chicago, Illinois +139 locations

Rush University Medical Center, Chicago, Illinois

University of Iowa, Iowa City, Iowa

Norton Cancer Institute, Louisville, Kentucky

Tufts Medical Center, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Rogel Cancer Center, Ann Arbor, Michigan

Mayo Clinic - Rochester, Rochester, Minnesota

Saint Louis University Hospital, Saint Louis, Missouri

John Theurer Cancer Center at Hackensack UMC, Hackensack, New Jersey

Morristown Medical Center, Morristown, New Jersey

Weill Cornell Medical College New York Presbyterian Hospital, New York, New York

Stony Brook University Hospital, Stony Brook, New York

Wake Forest Baptist Medical Center, Winston-Salem, North Carolina

Cleveland Clinic Foundation, Cleveland, Ohio

Stephenson Cancer Center, Oklahoma City, Oklahoma

Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas

San Antonio Military Medical Center, Fort Sam Houston, Texas

Border Medical Oncology, East Albury, New South Wales

Northern NSW Local Health District The Tweed Hospital, Tweed Heads, South Wales

Epworth Hospital, East Melbourne, Victoria

North Building, Frankston, Victoria

Andrew Love Cancer Centre, Geelong, Victoria

Olivia Newton John Cancer Wellness & Research Centre, Heidelberg, Victoria

Fiona Stanley Hospital, Murdoch, Western Australia

Royal Perth Hospital, Perth, Western Australia

Cross Cancer Institute, Edmonton, Alberta

QEII Health Science Centre - Halifax location, Halifax, Nova Scotia

Peking University Cancer Hospital (Beijing Cancer Hospital) (Beijing Institute for Cancer Research), Beijing, Beijing

Peking Union Medical College Hospital, Beijing, Beijing

Institute of Hematology & Blood Diseases Hospital, Tianjin, Beijing

Second Affiliated Hospital - Xinqiao Hospital, Chongqing, Chongqing

Sun Yat-Sen University Cancer Center - Cancer Prevention and Treatment Center, Sun Yat-sen University, Guangzhou, Guangdong

The Affiliated Tumor Hospital, Harbin, Heilongjiang

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan

Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei

Renmin Hospital of Wuhan University - Hubei Provincial People's Hospital, Wuhan, Hubei

The First Affiliated Hospital - Soochow University, Suzhou, Jiangsu

The First Bethune Hospital, Changchun, Jilin

The First Affiliated Hospital of Xi 'an Jiaotong University, Xi'an, Shaanxi

Shanhai Cancer Center, Shanghai, Shanghai

West China Hospital, Chengdu, Sichuan

Tianjin Medical University Cancer Institute, Tianjin, Tianjin

The First Hospital affiliated to the Medical School of Zhejiang University, Hangzhou, Zhejiang

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang

Peking University - Third Hospital, Beijing, Not set

Hopital Haut-Leveque, Pessac, Aquitaine

Centre Hospitalier Universitaire de Caen - Hematologie Clinique IHBN, Caen, Calvados

Unite Hemopathies Lymphoides Hospital Henri Mondor, Créteil, Ile-de-France

CHU Hotel Dieu Service Hematologie, Nantes, Loire

Hopital Lyon Sud, Pierre-Benite, Lyon

Hopital Claude Huriez - CHR Lille, Lille, Nord

Chu Poitiers - Pole Regional De Cancerologie, Poitiers, Vienne

Hopital Saint Louis, Paris, Not set

Hospital de la Pitie-Salpetriere, Paris, Not set

Klinik fur Innere Medizin II - Schwarzwald Baar Klinikum, Villingen-Schwenningen, Donaueschingen

Kliniken Ostalb Stauferklinikum Schwab Gmund, Mutlangen, Gmund

Klinikum Chemnitz, Chemnitz, Not set

University Hospital Halle Saale, Halle Saale, Not set

Universitatsklinik Wurzburg, Med Klinik und Poliklinik II, Zentrum Innere Medizin, Wurzburg, Not set

IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia

UOC Hematologia, Fondazione IRCCS, Ca Granda, OM Policlinico, Milano, Milan

University of Bologna Dipartimento di Medicina Specialistica Diagnostica e Sperimentale, Bologna, Not set

Azienda Ospedaliera Careggi, Firenze, Not set

Uos Ematologia - Ospedale Civile di Livorno, Livorno, Not set

ASST Grande Ospedale Metropolitano Niguarda - Division of Hematology, Milano, Not set

AOU Maggiore della Carita, Novara, Not set

Presidio Ospedaliero Santa Maria della Misericordia, Perugia, Not set

Ospedale Santa Maria delle Croci, Ravenna, Not set

Arcispedale Santa Maria Nuova, Reggio Emilia, Not set

Azienda Ospedaliera Santa Maria Terni, Terni, Not set

Ospedale dell'Angelo - Varese, Varese, Not set

Ospedale DellAngelo Di Mestre, Venice, Not set

Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Aichi

National Hospital Organization Nagoya Medical Center, Nagoya, Aiti

National Cancer Center Hospital East, Kashiwa-shi, Chiba-ken

National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime

National Hospital Organization National Kyushu Cancer Center, Fukuoka-shi, Hukuoka

Kobe City Medical Center General Hospital, Kobe, Hyogo

Tokai University Hospital, Isehara-Shi, Kanagawa

University Hospital Kyoto Prefectural University of Medicine, Kyoto City, Kyoto

Osaka Metropolitan University Hospital, Osaka City, Osaka

Saitama Medical University International Medical Center, Hidaka, Saitama

Chiba Cancer Center, Chiba-shi, Tiba

National Cancer Center Hospital - Tsukiji Campus, Chuo ku, Tokyo

Yamagata University Hospital, Yamagata City, Yamagata Prefecture

Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Not set

Keimyung University Dongsan Medical Center, Daegu si, Daegu

University of Ulsan College of Medicine, Ulsan, Daegu

National Cancer Center, Gyeonggi do, Gyeonggi

Korea University Anam Hospital, Seoul, Gyeonggi

Dong-A University Hospital, Busan, Not set

Seoul National University Hospital, Seoul, Not set

Severance Hospital, Seoul, Not set

Samsung Medical Center, Seoul, Not set

The Catholic University of Korea Seoul St Marys Hospital, Seoul, Not set

Ewha Womans University Mokdong Hospital - Hemato Oncology, Seoul, Not set

Matopolskie Centrum Medyczne S.C., Krakow, Malopolskie

Centrum Onkologii Instytut im M Sklodowskiej CurieOddzial Chorob United Kingdomladu Chlonnego, Warszawa, Mazowieckie

Uniwersyteckie Centrum, Gdansk, Pomorskie

Pomorskie Hospitals SP. Z O. O. Oncology And Radiotherapy Ward, Gdynia, Pomorskie

Uniwersyteckie Centrum Kliniczne, Gdańsk, Not set

Szpitale Pomorskie spSp. Z.o.o., Gdynia, Not set

Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. Mikolaja Kopernika w Lodzi (Copernicus Memorial Hospital), Lodz, Not set

Instytut Hematologii I Transfuzjologii Klinika Hematologii, Warszawa, Not set

Uniwersytecki Szpital Kliniczny we Wroclawiu, Klinika Hematologii, Terapii Komorkowych i Chorob Wewnetrznych, Wroclaw, Not set

National University Hospital, Singapore, Not set

Singapore General Hospital, Singapore, Not set

Raffles Cancer Centre, Singapore, Not set

Icon Soc Farrer Park, Singapore, Not set

Hospital Universitari Son Espases, Palma, Balearic Islands

Ico Lhospitalet - Hospital Duran i Reynals, Barcelona, Catalonia

Hospital Universitario Donostia, Donostia, Gipuzkoa

Hospital Son Llatzer, Palma, Illes Balears

Hospital Universitario Quiron Salud Madrid, Pozuelo de Alarcon, Madrid

Hospital Costa del Sol, Marbella, Malaga

Hospital Universitario Vall d'Hebron, Barcelona, Not set

Hospital Clinic de Barcelona - Planta 4 Escalera, Barcelona, Not set

Hospital de la Santa Creu i Sant Pau, Barcelona, Not set

MD Anderson Cancer Center- Madrid, Madrid, Not set

Hospital Universitario Fundacion Jimenez Diaz, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario HM Sanchinarro, Madrid, Not set

Hospital Universitario de Salamanca, Salamanca, Not set

Hospital Universitari i Politecnic La Fe, Valencia, Not set

Chang Gung Memorial Hospital Kaohsiung, Kaohsiung City, Not set

Taipei Medical University - Shuang Ho Hospital, New Taipei City, Not set

China Medical University, Taichung City, Not set

National Cheng Kung University, Tainan City, Not set

Chi-Mei Medical Center - Liuying, Tainan, Not set

National Taiwan University Hospital, Taipei City, Not set

Mackay Memorial Hospital, Taipei City, Not set

Koo Foundation Sun Yat-Sen Cancer Center, Taipei City, Not set

Tri-Service General Hospital, Taipei, Not set

Chang Gung Medical Foundation-, Taoyuan, Not set

Royal Cornwall Hospital, Truro, Cornwall

Derriford Hospital and the Royal Eye Infirmary, Plymouth, Devon

Western General Hospital, Edinburgh, Scotland

The Royal Marsden Hospital, Sutton, Surrey

University Hospital of Wales, Cardiff, Wales

Kings College Hospital, London, Not set

Conditions: B-cell Non-Hodgkin Lymphoma (B-NHL)

Learn More ›

Treatment Outcomes With tDCS in Post-Stroke Aphasia

NCT03929432

Recruiting

The purpose this study is to test the utility of pairing external neuromodulation with behavioral language treatment to boost therapy outcomes and to investigate the mechanisms associated with recovery. Because all PWA have word retrieval deficits, this project will test if greater language gains can be achieved by supplementing anomia intervention with excitatory brain stimulation to the left hemisphere and will evaluate associated functional brain changes to aid the optimization of neural reor... Read More

Gender:

ALL

Ages:

Between 18 years and 80 years

Trial Updated:

07/14/2025

Locations: University of Arkansas for Medical Sciences, Little Rock, Arkansas

Conditions: Aphasia

Learn More ›

Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics

NCT03953300

Recruiting

The purpose of the study is to evaluate effect of benralizumab on structural and lung function changes in severe eosinophilic asthmatics. Changes will be assessed over 48 week treatment period in patients with persistent symptoms despite standard therapy of inhaled corticosteroids (ICS) plus long acting B2-agonist (LABA) with or without additional controller medication. Patients who complete treatment will enter 4 weeks follow-up period.

Gender:

ALL

Ages:

Between 18 years and 70 years

Trial Updated:

07/14/2025

Locations: Research Site, Birmingham, Alabama +52 locations

Research Site, Birmingham, Alabama

Research Site, Los Angeles, California

Research Site, Jacksonville, Florida

Research Site, Miami, Florida

Research Site, Decatur, Georgia

Research Site, Snellville, Georgia

Research Site, Indianapolis, Indiana

Research Site, Iowa City, Iowa

Research Site, Hutchinson, Kansas

Research Site, Kansas City, Kansas

Research Site, Baltimore, Maryland

Research Site, Boston, Massachusetts

Research Site, Ann Arbor, Michigan

Research Site, Bloomfield Hills, Michigan

Research Site, Rochester, Minnesota

Research Site, Saint Louis, Missouri

Research Site, Maspeth, New York

Research Site, Port Jefferson Station, New York

Research Site, Durham, North Carolina

Research Site, New Bern, North Carolina

Research Site, Winston-Salem, North Carolina

Research Site, Philadelphia, Pennsylvania

Research Site, Pittsburgh, Pennsylvania

Research Site, Sayre, Pennsylvania

Research Site, Charleston, South Carolina

Research Site, Galveston, Texas

Research Site, Lewisville, Texas

Research Site, Mansfield, Texas

Research Site, McAllen, Texas

Research Site, McKinney, Texas

Research Site, Williamsburg, Virginia

Research Site, Calgary, Alberta

Research Site, Edmonton, Alberta

Research Site, Hamilton, Ontario

Research Site, Aarhus N, Not set

Research Site, Hvidovre, Not set

Research Site, København, Not set

Research Site, Naestved, Not set

Research Site, Odense C, Not set

Research Site, Vejle, Not set

Research Site, Ålborg, Not set

Research Site, Göteborg, Not set

Research Site, Lund, Not set

Research Site, Cambridge, Not set

Research Site, Headington, Not set

Research Site, Leicester, Not set

Research Site, Liverpool, Not set

Research Site, London, Not set

Research Site, Wythenshawe, Not set

Conditions: Asthma

Learn More ›

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

NCT03998202

Recruiting

This study will examine the association between low muscle mass (myopenia) at diagnosis and chemotherapy toxicity in older adults with newly diagnosed advanced colorectal cancer.

Gender:

ALL

Ages:

60 years and above

Trial Updated:

07/14/2025

Locations: Beebe South Coastal Health Campus, Millville, Delaware +142 locations

Beebe South Coastal Health Campus, Millville, Delaware

Helen F Graham Cancer Center, Newark, Delaware

Medical Oncology Hematology Consultants PA, Newark, Delaware

Beebe Health Campus, Rehoboth Beach, Delaware

Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware

MedStar Georgetown University Hospital, Washington, District of Columbia

John B Amos Cancer Center, Columbus, Georgia

Illinois CancerCare-Bloomington, Bloomington, Illinois

Illinois CancerCare-Canton, Canton, Illinois

John H Stroger Jr Hospital of Cook County, Chicago, Illinois

Carle at The Riverfront, Danville, Illinois

Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois

Crossroads Cancer Center, Effingham, Illinois

Illinois CancerCare-Galesburg, Galesburg, Illinois

Carle Physician Group - Mattoon/Charleston, Mattoon, Illinois

SSM Health Good Samaritan, Mount Vernon, Illinois

Cancer Care Center of O'Fallon, O'Fallon, Illinois

Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois

Illinois CancerCare-Pekin, Pekin, Illinois

Illinois CancerCare-Peoria, Peoria, Illinois

Illinois CancerCare-Peru, Peru, Illinois

Southern Illinois University School of Medicine, Springfield, Illinois

Springfield Clinic, Springfield, Illinois

Carle Cancer Center, Urbana, Illinois

Illinois CancerCare - Washington, Washington, Illinois

The University of Iowa - Ankeny, Ankeny, Iowa

Saint Anthony Regional Hospital, Carroll, Iowa

Physicians' Clinic of Iowa PC, Cedar Rapids, Iowa

Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa

UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa

Iowa Methodist Medical Center, Des Moines, Iowa

The University of Iowa-Des Moines, Des Moines, Iowa

Broadlawns Medical Center, Des Moines, Iowa

Mercy Medical Center - Des Moines, Des Moines, Iowa

UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa

Trinity Regional Medical Center, Fort Dodge, Iowa

Saint Joseph Hospital East, Lexington, Kentucky

Louisiana Hematology Oncology Associates LLC, Baton Rouge, Louisiana

Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana

MBP Cancer Center - Baton Rouge General, Baton Rouge, Louisiana

Terrebonne General Medical Center, Houma, Louisiana

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan

Trinity Health IHA Medical Group Hematology Oncology-Brighton, Brighton, Michigan

Trinity Health Medical Center-Brighton, Brighton, Michigan

Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan

Trinity Health Medical Center - Canton, Canton, Michigan

Chelsea Hospital, Chelsea, Michigan

Trinity Health IHA Hematology Oncology Consultants-Chelsea Hospital, Chelsea, Michigan

Cancer Hematology Centers - Flint, Flint, Michigan

Genesee Hematology Oncology PC, Flint, Michigan

Genesys Hurley Cancer Institute, Flint, Michigan

Marshfield Medical Center Dickinson, Iron Mountain, Michigan

Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan

Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan

Corewell Health Reed City Hospital, Reed City, Michigan

University of Michigan Health - West, Wyoming, Michigan

Trinity Health IHA Medical Group Hematology Oncology -Ann Arbor, Ypsilanti, Michigan

Sanford Joe Lueken Cancer Center, Bemidji, Minnesota

Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota

Mercy Hospital, Coon Rapids, Minnesota

Essentia Health - Deer River Clinic, Deer River, Minnesota

Essentia Health Saint Mary's - Detroit Lakes Clinic, Detroit Lakes, Minnesota

Essentia Health Cancer Center, Duluth, Minnesota

Fairview Southdale Hospital, Edina, Minnesota

Essentia Health Hibbing Clinic, Hibbing, Minnesota

Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota

Saint John's Hospital - Healtheast, Maplewood, Minnesota

Abbott-Northwestern Hospital, Minneapolis, Minnesota

Health Partners Inc, Minneapolis, Minnesota

New Ulm Medical Center, New Ulm, Minnesota

Essentia Health - Park Rapids, Park Rapids, Minnesota

Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota

Regions Hospital, Saint Paul, Minnesota

United Hospital, Saint Paul, Minnesota

Essentia Health Sandstone, Sandstone, Minnesota

Saint Francis Regional Medical Center, Shakopee, Minnesota

Essentia Health Virginia Clinic, Virginia, Minnesota

Rice Memorial Hospital, Willmar, Minnesota

Saint Francis Medical Center, Cape Girardeau, Missouri

Parkland Health Center - Farmington, Farmington, Missouri

Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri

Heartland Regional Medical Center, Saint Joseph, Missouri

Missouri Baptist Medical Center, Saint Louis, Missouri

Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri

Mercy Hospital Springfield, Springfield, Missouri

CoxHealth South Hospital, Springfield, Missouri

Missouri Baptist Sullivan Hospital, Sullivan, Missouri

BJC Outpatient Center at Sunset Hills, Sunset Hills, Missouri

Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina

Atrium Health Pineville/LCI-Pineville, Charlotte, North Carolina

Levine Cancer Institute-SouthPark, Charlotte, North Carolina

Atrium Health University City/LCI-University, Charlotte, North Carolina

Wake Forest University at Clemmons, Clemmons, North Carolina

Atrium Health Cabarrus/LCI-Concord, Concord, North Carolina

Levine Cancer Institute-Gaston, Gastonia, North Carolina

Wake Forest Baptist Health - Wilkes Medical Center, Wilkesboro, North Carolina

Wake Forest University Health Sciences, Winston-Salem, North Carolina

Sanford Bismarck Medical Center, Bismarck, North Dakota

Essentia Health Cancer Center-South University Clinic, Fargo, North Dakota

Sanford Broadway Medical Center, Fargo, North Dakota

Sanford Roger Maris Cancer Center, Fargo, North Dakota

Adena Regional Medical Center, Chillicothe, Ohio

The Mark H Zangmeister Center, Columbus, Ohio

Armes Family Cancer Center, Findlay, Ohio

Knox Community Hospital, Mount Vernon, Ohio

Licking Memorial Hospital, Newark, Ohio

Southern Ohio Medical Center, Portsmouth, Ohio

Springfield Regional Cancer Center, Springfield, Ohio

Genesis Healthcare System Cancer Care Center, Zanesville, Ohio

Geisinger Medical Center, Danville, Pennsylvania

Geisinger Medical Center-Cancer Center Hazleton, Hazleton, Pennsylvania

Geisinger Medical Oncology-Lewisburg, Lewisburg, Pennsylvania

Lewistown Hospital, Lewistown, Pennsylvania

Geisinger Cancer Services-Pottsville, Pottsville, Pennsylvania

Community Medical Center, Scranton, Pennsylvania

Geisinger Medical Oncology-Selinsgrove, Selinsgrove, Pennsylvania

Geisinger Medical Group, State College, Pennsylvania

Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania

Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina

Prisma Health Cancer Institute - Easley, Easley, South Carolina

Gibbs Cancer Center-Gaffney, Gaffney, South Carolina

Prisma Health Cancer Institute - Butternut, Greenville, South Carolina

Prisma Health Cancer Institute - Faris, Greenville, South Carolina

Prisma Health Cancer Institute - Eastside, Greenville, South Carolina

Self Regional Healthcare, Greenwood, South Carolina

Prisma Health Cancer Institute - Greer, Greer, South Carolina

Gibbs Cancer Center-Pelham, Greer, South Carolina

Prisma Health Cancer Institute - Seneca, Seneca, South Carolina

Spartanburg Medical Center, Spartanburg, South Carolina

MGC Hematology Oncology-Union, Union, South Carolina

Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota

Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota

Duluth Clinic Ashland, Ashland, Wisconsin

Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin

Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin

Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin

Marshfield Medical Center-Marshfield, Marshfield, Wisconsin

Marshfield Medical Center - Minocqua, Minocqua, Wisconsin

Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin

Essentia Health-Spooner Clinic, Spooner, Wisconsin

Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin

Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin

Marshfield Medical Center - Weston, Weston, Wisconsin

Conditions: Colorectal Cancer, Sarcopenia

Learn More ›

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

NCT04049669

Recruiting

Indoximod was developed to inhibit the IDO (indoleamine 2,3-dioxygenase) enzymatic pathway, which is important in the natural regulation of immune responses. This potent immune suppressive mechanism has been implicated in regulating immune responses in settings as diverse as infection, tissue/organ transplant, autoimmunity, and cancer. By inhibiting the IDO pathway, we hypothesize that indoximod will improve antitumor immune responses and thereby slow the growth of tumors. The central clinical... Read More

Gender:

ALL

Ages:

Between 3 years and 21 years

Trial Updated:

07/14/2025

Locations: Augusta University, Georgia Cancer Center, Augusta, Georgia +4 locations

Conditions: Glioblastoma, Medulloblastoma, Ependymoma, Diffuse Intrinsic Pontine Glioma

Learn More ›

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

NCT04064060

Recruiting

A Phase 3b, open-label, single-arm, rollover study to evaluate the long-term safety of luspatercept, to the following participants: * Participants receiving luspatercept on a parent protocol at the time of their transition to the rollover study, who tolerate the protocol-prescribed regimen in the parent trial and, in the opinion of the investigator, may derive clinical benefit from continuing treatment with luspatercept * Participants in the follow-up phase previously treated with luspatercept or placebo in the parent protocol will continue into long-term post-treatment follow-up in the rollover study until the follow-up commitments are met * The study design is divided into the Transition Phase, Treatment Phase and Follow-up Phase. Participants will enter transition phase and depending on their background will enter either the treatment phase or the Long-term Post-treatment Follow-up (LTPTFU) phase * Transition Phase is defined as one Enrollment visit * Treatment Phase: For participants in luspatercept treatment the dose and schedule of luspatercept in this study will be the same as the last dose and schedule in the parent luspatercept study. This does not apply to participants that are in long-term follow-up from the parent protocol * Follow-up Phase includes: - 42 Day Safety Follow-up Visit * During the Safety Follow up, the participants will be followed for 42 days after the last dose of luspatercept, for the assessment of safety-related parameters and adverse event (AE) reporting - Long-term Post-treatment Follow-up (LTPTFU) Phase * Participants will be followed for overall survival every 6 months for at least 5 years from first dose of luspatercept in the parent protocol, or 3 years of post-treatment from last dose, whichever occurs later, or until death, withdrawal of consent, study termination, or until a subject is lost to follow-up. Participants will also be monitored for progression to AML or any malignancies/pre-malignancies. New anticancer or disease related therapies should be collected at the same time schedule Participants transitioning from a parent luspatercept study in post-treatment follow-up (safety or LTPTFU) will continue from the same equivalent point in this rollover study. The ACE-536-LTFU-001 rollover study will be terminated, and relevant participants will discontinue from the study when all participants fulfill 5 years on the study, including treatment and follow-up. Read Less

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/14/2025

Locations: Childrens Hospital Los Angeles RHU, Los Angeles, California +142 locations

Childrens Hospital Los Angeles RHU, Los Angeles, California

Local Institution - 971, Oakland, California

Local Institution - 978, Stanford, California

Local Institution - 975, Tampa, Florida

Local Institution - 970, Chicago, Illinois

Local Institution - 973, Boston, Massachusetts

Local Institution - 961, Detroit, Michigan

Local Institution - 969, New York, New York

Local Institution - 967, Cleveland, Ohio

Local Institution - 972, Philadelphia, Pennsylvania

Vanderbilt - Ingram Cancer Center, Nashville, Tennessee

The University of Texas - MD Anderson Cancer Center, Houston, Texas

Local Institution - 100, South Brisbane, Queensland

Royal Adelaide Hospital, Adelaide, South Australia

Local Institution - 102, Clayton, Victoria

Royal Prince Alfred Hospital, Camperdown, Not set

Local Institution - 182, Brasschaat, Not set

Local Institution - 180, Brugge, Not set

Local Institution - 183, Ghent, Not set

Local Institution - 184, Leuven, Not set

Local Institution - 220, Boulevard, Sofia

Local Institution - 221, Plovdiv, Not set

Local Institution - 262, Toronto, Ontario

Local Institution - 260, Toronto, Ontario

Local Institution - 263, Toronto, Ontario

Local Institution - 131, Beijing, Beijing

Local Institution - 135, Guangzhou, Guangdong

Local Institution - 132, Shanghai, Shanghai

Local Institution - 134, Chengdu, Sichuan

Local Institution - 130, Tianjin, Tianjin

Local Institution - 133, Hangzhou, Zhejiang

Local Institution - 305, Angers, Not set

Local Institution - 300, Creteil, Not set

Local Institution - 310, La Tronche, Not set

Local Institution - 306, Lille, Not set

Local Institution - 301, Marseille Cedex 9, Not set

Local Institution - 302, Paris, Not set

Local Institution - 307, Pessac Cedex, Not set

Local Institution - 304, Pierre Benite cedex, Not set

Local Institution - 308, Strasbourg, Not set

Local Institution - 309, Toulouse Cedex 9, Not set

Local Institution - 303, Tours, Not set

Local Institution - 341, Berlin, Not set

Local Institution - 348, Dresden, Not set

Local Institution - 345, Duesseldorf, Not set

Local Institution - 346, Dusseldorf, Not set

Local Institution - 343, Halle, Not set

Local Institution - 342, Hamburg, Not set

Local Institution - 344, Hannover, Not set

Local Institution - 349, Leipzig, Not set

Local Institution - 340, Mainz, Not set

Local Institution - 347, München, Not set

Aghia Sophia' Children's General Hospital of Athens, Athens, Not set

Laiko General Hospital of Athens - Center of Thalassemia, Athens, Not set

Local Institution - 384, Athens, Not set

Local Institution - 383, Rio Patras, Not set

Local Institution - 381, Thessaloniki, Not set

Local Institution - 425, Afula, Not set

Rambam Health Corporation, Haifa, Not set

Local Institution - 422, Jerusalem, Not set

Local Institution - 424, Jerusalem, Not set

Local Institution - 421, Nahariya, Not set

Local Institution - 423, Petah Tikva, Not set

Local Institution - 478, Firenze, Toscana

Local Institution - 471, Firenze, Toscana

Local Institution - 470, Allessandria, Not set

Local Institution - 464, Bologna, Not set

Local Institution - 466, Brindisi, Not set

Local Institution - 477, Cagliari, Not set

Local Institution - 462, Ferrara, Not set

Ente Ospedaliero Ospedali Galliera - Centro della Microcitemia e delle Anemie Congenite, Genoa, Not set

Local Institution - 473, Lecce, Not set

Maggiore Polyclinic Hospital, IRCCS Ca' Granda, Milano, Not set

Local Institution - 479, Modena, Not set

AORN A Cardarelli, Napoli, Not set

AOU dell'Universita degli Studi della Campania Luigi Vanvitelli, Napoli, Not set

Azienda Ospedaliero Universitaria S. Luigi Gonzaga, Orbassano, Not set

Local Institution - 469, Pavia, Not set

Local Institution - 468, Reggio Di Calabria, Not set

Local Institution - 465, Roma, Not set

Local Institution - 474, Rozzano, Not set

Local Institution - 472, Varese, Not set

Local Institution - 463, Verona, Not set

Local Institution - 610, Nagoya, Aichi

Local Institution - 601, Kamogawa, Chiba

Matsuyama Red Cross Hospital, Matsuyama, Ehime

Ogaki Municipal Hospital, Ogaki, Gifu

Japanese Red Cross Society Himeji Hospital, Himeji, Hyogo

Local Institution - 605, Hitachi, Ibaraki

Kitasato University Hospital, Sagamihara, Kanagawa

Local Institution - 0979, Sendai, Miyagi

Tohoku University Hospital, Sendai, Miyagi

Local Institution - 611, Nagasaki-shi, Nagasaki

Japanese Red Cross Medical Center, Shibuya City, Tokyo

NTT Medical Center Tokyo, Shinagawa City, Tokyo

Local Institution - 612, Chiba, Not set

Shonan Kamakura General Hospital, Kamakura, Not set

Osaka Metropolitan University Hospital, Osaka, Not set

Local Institution - 604, Osaka, Not set

Chronic Care Center, Hazmieh, Not set

Local Institution - 545, Johor Bahru, Johor

Hospital Sultanah Bahiyah, Alor Setar, Kedah

Hospital Raja Permaisuri Bainun, Ipoh, Perak

Queen Elizabeth Hospital, Kota Kinabalu, Sabah

Hospital Umum Sarawak, Kuching, Sarawak

University Malaya Medical Centre, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur

Local Institution - 580, Amsterdam, Not set

Local Institution - 681, Barakaldo, Not set

Local Institution - 686, Barcelona, Not set

Local Institution - 685, Barcelona, Not set

Local Institution - 687, Madrid, Not set

Local Institution - 682, Oviedo, Not set

Local Institution - 684, Salamanca, Not set

Local Institution - 680, Seville, Not set

Local Institution - 683, Valencia, Not set

Local Institution - 720, Goteborg, Not set

Local Institution - 722, Lund, Not set

Local Institution - 721, Stockholm, Not set

Local Institution - 760, Kaohsiung, San Ming Dist., Not set

China Medical University Hospital, Taichung, Not set

Local Institution - 761, Taipei, Not set

Chulalongkorn University Faculty of Medicine - King Chulalongkorn Memorial Hospital, Bangkok, Not set

Siriraj Hospital Mahidol University, Bangkok, Not set

Chiang Mai University - Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Not set

University Hospital Farhat Hached, Sousse, Not set

Bone Marrow Transplant Center, Tunis, Not set

Aziza Othmana Hospital, Tunis, Not set

Military Hospital of Tunis, Tunis, Not set

Acibadem Adana Hospital, Adana, Not set

Local Institution - 885, Ankara, Not set

Local Institution - 882, Istanbul, Not set

Local Institution - 884, Istanbul, Not set

Local Institution - 880, Izmir, Not set

Local Institution - 883, Mersin, Not set

Local Institution - 925, Aberdeen, Not set

Local Institution - 921, Leeds, Not set

Local Institution - 923, London, Not set

Whittington Hospital, London, Not set

University College London Hospitals NHS Foundation Trust - University College Hospital, London, Not set

Local Institution - 928, London, Not set

Local Institution - 924, London, Not set

Local Institution - 929, Oxford, Not set

Local Institution - 926, Sutton in Ashfield, Not set

Conditions: Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis

Learn More ›